-+ 0.00%
-+ 0.00%
-+ 0.00%

Vor Biopharma Q2 EPS $(1.16) Misses $(0.70) Estimate

Benzinga·08/11/2026 13:36:25
Listen to the news
Vor Biopharma (NASDAQ:VOR) reported quarterly losses of $(1.16) per share which missed the analyst consensus estimate of $(0.70) by 65.71 percent. This is a 99.54 percent increase over losses of $(251.24) per share from the same period last year.